Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice

Prevalence of chronic comorbidities in chikungunya: A systematic review and meta-analysis

(2018) Alaa Badawi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Prognostic factors of inhospital death in elderly patients: a time-to-event analysis of a cohort study in Martinique (French West Indies)

(2018) Lidvine Godaert et al.   BMJ Open

Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity

(2018) Fok-Moon Lum et al.   Scientific Reports

Severe manifestations of chikungunya virus in critically ill patients during the 2013–2014 Caribbean outbreak

(2016) Laura Crosby et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus

(2016) Adam D. DeZure et al.   JOURNAL OF INFECTIOUS DISEASES

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

(2016) Slim Fourati et al.   Nature Communications

Dysregulated TGF-β Production Underlies the Age-Related Vulnerability to Chikungunya Virus

(2016) Jennifer L. Uhrlaub et al.   PLoS Pathogens

Expression and Purification of Virus-like Particles for Vaccination

(2016) Maria T. Arevalo et al.   Jove-Journal of Visualized Experiments

Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity

(2015) Paola Lucia Minciullo et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

A sensitive epitope-blocking ELISA for the detection of Chikungunya virus-specific antibodies in patients

(2015) Lucas Y.H. Goh et al.   JOURNAL OF VIROLOGICAL METHODS

Chikungunya virus–associated encephalitis

(2015) Patrick Gérardin et al.   NEUROLOGY

Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines

(2015) Jorge A. Salazar-González et al.   VACCINE

Immunosenescence and vaccine failure in the elderly: Strategies for improving response

(2014) Diana Boraschi et al.   IMMUNOLOGY LETTERS

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

(2014) Lee-Jah Chang et al.   LANCET

Multiple Immune Factors Are Involved in Controlling Acute and Chronic Chikungunya Virus Infection

(2014) Yee Suan Poo et al.   PLoS Neglected Tropical Diseases

Impaired Antibody Response to Influenza Vaccine in HIV-Infected and Uninfected Aging Women Is Associated with Immune Activation and Inflammation

(2013) Anita Parmigiani et al.   PLoS One

Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells

(2013) Stefan W. Metz et al.   PLoS Neglected Tropical Diseases

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein

(2012) Yiu-Wing Kam et al.   EMBO Molecular Medicine

A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice

(2012) T.-H. Teo et al.   JOURNAL OF IMMUNOLOGY

Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection

(2012) Yiu-Wing Kam et al.   JOURNAL OF INFECTIOUS DISEASES

Chikungunya Virus Arthritis in Adult Wild-Type Mice

(2010) J. Gardner et al.   JOURNAL OF VIROLOGY

Systemic involvements and fatalities during Chikungunya epidemic in India, 2006

(2009) Babasaheb V. Tandale et al.   JOURNAL OF CLINICAL VIROLOGY

Biology of Immune Responses to Vaccines in Elderly Persons

(2008) Birgit Weinberger et al.   CLINICAL INFECTIOUS DISEASES

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion

(2008) A. ECONOMOPOULOU et al.   EPIDEMIOLOGY AND INFECTION